← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2007Last known activity
Mar 20, 2023
Timeline
2000s
- Jan 1, 2007
Arbeitsgemeinschaft medikamentoese Tumortherapie— Founded
Drugs by trial phase (43 distinct, 33 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiotoxicity
- Colorectal Neoplasms
- Esophageal Neoplasms
- Head and Neck Neoplasms
- HIV Infections
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Multiple Myeloma
- Nausea
- Neoplasms
- Neoplasms, Plasma Cell
- Oropharyngeal Neoplasms
- Pancreatic Neoplasms
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
- Vomiting
Recent trials (35)
- NCT05798156CollaboratorPhase 2Mar 20, 2023
- NCT04891809Lead sponsorPhase 2Oct 20, 2021
- NCT03984214Lead sponsorPhase 3Oct 15, 2019
- NCT03792763Lead sponsorPhase 2Jun 30, 2019
- NCT02891811Lead sponsorPhase 2Mar 10, 2017
- NCT02236936Lead sponsorPhase 3Feb 3, 2017
- NCT02987400Lead sponsorPhase 2Jan 1, 2017
- NCT02993094Lead sponsorPhase 1/Phase 2Nov 1, 2016
- NCT02462538Lead sponsorPhase 1/Phase 2May 1, 2015
- NCT02410694Lead sponsorPhase 2Apr 1, 2015
- NCT02097108Lead sponsorPhase 2May 1, 2014
- NCT01891227Lead sponsorPhase 2Aug 1, 2013
- NCT01933906Lead sponsorPhase 1Aug 1, 2013
- NCT01884259Lead sponsorPhase 2May 1, 2013
- NCT01703390Lead sponsorPhase 2Aug 1, 2012
Details
- Founded
- Salzburg, AT Jan 1, 2007
- Last known activity
- Mar 20, 2023